Medicine
ADHD drugs might also treat Alzheimer’s disease
Scientists reviewed 40 years of clinical studies that assessed the effects of NA-targeting drugs, such as certain ADHD drugs, on Alzheimer’s.
A cheap nasal spray cuts COVID-19 risk by 62%
A low-cost nasal spray co-developed by Oxford researchers could be the next powerful weapon against COVID-19.
Your genes may impact psychedelic experiences
UNC researchers have found evidence that the genetic makeup of a crucial receptor may impact your psychedelic experience.
Harvard scientists closer to solving centuries-old heart mystery
Harvard researchers have used a new method to crack the heart’s weird spiral muscle.
MIT engineers 3D-print rubbery brain implants that don’t “stab” the brain
How do you engineer an implant that doesn't harm an organ as soft as tofu? MIT engineers 3D-printed new soft brain implants.
How child mortality fell from 40% to 3.7% in 200 years
The collapse in child mortality rates is a testament to the tremendous benefits of scientific, technological, and economic progress.
Large study of 20,000 cats and dogs could help pets live longer
Mars Petcare has announced the opening of a massive biobank to study aging and pet diseases.
Potential cause of unexplained epilepsy cases uncovered
University of Arizona researchers have uncovered a protein that might be behind some epilepsy cases with currently unknown causes.
The first FDA-approved clinical trial of psilocin has begun
“This has never been done before,” says Filament’s CEO.
Nasal COVID-19 vaccines prepare for infection right where it starts – in your nose and throat
Intranasal vaccines are best suited to protect against pathogens that enter through the nose, like the flu or the coronavirus.